Nordion Settles Dr. Reddy's $80M Negligent Testing Suit

Law360, New York (March 22, 2013, 1:51 PM EDT) -- Medical equipment and research company Nordion Inc. said Thursday it has agreed to settle a lawsuit in New Jersey federal court in which Dr. Reddy’s Laboratories Inc. claimed poor testing conditions at a Nordion unit’s laboratories cost it more than $80 million in retesting and delayed and abandoned generic drug approvals.

The deal ends claims that Nordion's former business unit MDS Pharma Services Inc. failed to maintain good laboratory practices at two of its facilities, costing Dr. Reddy's $80 million in lost profits and retesting costs...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.